Education
About Us
Working with TipRanks
Follow Us
InhaleRx Limited (AU:IRX)
ASX:IRX
IRX Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.01 - AU$0.05
Previous CloseN/A
Volume3.50K
Average Volume (3M)68.37K
Market Cap
AU$5.76M
Enterprise ValueAU$4.73M
Total Cash (Recent Filing)AU$1.32M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta-1.06
Next Earnings
Aug 29, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding213,448,230
10 Day Avg. Volume110,419
30 Day Avg. Volume68,369
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)314.00
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
InhaleRx Limited News
PremiumCompany Announcements
InhaleRx Limited Advances Clinical Programs in Pain and Mental Health
PremiumCompany Announcements
InhaleRx Advances Phase 2 Trial for Non-Opioid Cancer Pain Treatment
PremiumCompany Announcements
InhaleRx Limited Holds General Meeting and Announces Upcoming Webinar
PremiumCompany Announcements
InhaleRx Limited Announces Shareholder Webinar to Discuss Clinical Progress
PremiumCompany Announcements
InhaleRx Limited Announces Cessation of Securities
PremiumCompany Announcements
InhaleRx Ltd Appoints Tony Fitzgerald as New DirectorPremiumCompany Announcements
InhaleRx Limited Announces Virtual General Meeting for Shareholders
PremiumCompany Announcements
InhaleRx Limited Announces Proxy Voting Procedures for General Meeting---
Options Prices
Currently, No data available
---
Ownership Overview
17.99% Insiders
―
Mutual Funds
― Other Institutional Investors
82.01% Public Companies and
Individual Investors
IRX FAQ
What was InhaleRx Limited’s price range in the past 12 months?
InhaleRx Limited lowest share price was AU$0.01 and its highest was AU$0.05 in the past 12 months.
What is InhaleRx Limited’s market cap?
InhaleRx Limited’s market cap is AU$5.76M.
When is InhaleRx Limited’s upcoming earnings report date?
InhaleRx Limited’s upcoming earnings report date is Aug 29, 2025 which is in 155 days.
How were InhaleRx Limited’s earnings last quarter?
Currently, no data Available
Is InhaleRx Limited overvalued?
According to Wall Street analysts InhaleRx Limited’s price is currently Overvalued.
Does InhaleRx Limited pay dividends?
InhaleRx Limited does not currently pay dividends.
What is InhaleRx Limited’s EPS estimate?
InhaleRx Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does InhaleRx Limited have?
InhaleRx Limited has 213,448,230 shares outstanding.
What happened to InhaleRx Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of InhaleRx Limited?
Currently, no hedge funds are holding shares in AU:IRX
---
InhaleRx Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:IRX Sentiment 90%
Sector Average 69%
Sector Average 69%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-46.00%
12-Months-Change
Fundamentals
Return on Equity
-252.23%
Trailing 12-Months
Asset Growth
-48.07%
Trailing 12-Months
Company Description
InhaleRx Limited
InhaleRx Limited engages in the developing and commercializing of medical drug delivery systems in Australia. It also develops inhaled drug formulations. Its solutions include Medihale inhaler, a sealed pod inhaler for use with inhaled formulations. The company was formerly known as Lifespot Health Ltd and changed its name to InhaleRx Limited in October 2021. InhaleRx Limited was incorporated in 2016 and is based in Sydney, Australia.
---
Technical Analysis
Elixinol Wellness
―
Cann Group Ltd.
―
Althea Group Holdings Ltd.
―
Botanix Pharmaceuticals Limited
―
---